Predicting functional effects of missense variants in voltage-gated sodium and calcium channels
Open accessPublished version of a preprint
The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
A machine learning method can predict loss- versus gain-of-function effects of human genetic variants in disease-associated ion channels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MUSCLE: multiple sequence alignment with high accuracy and high throughput
Edgar, R. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh340 · Cited by 44,662
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu033 · Cited by 32,291
Greedy function approximation: A gradient boosting machine
Friedman, J. H. (2001) · The Annals of Statistics · doi:10.1214/aos/1013203451 · Cited by 30,731 · cited 1×
“The relative influence of features on the prediction normalized to sum to 100 is computed as described in (Friedman, 2001).”
MethodKabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Evolutionary trees from DNA sequences: A maximum likelihood approach.
Felsenstein, J. (1981) · Journal of Molecular Evolution · doi:10.1007/bf01734359 · Cited by 14,571
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Self-citationThe mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
Self-citationBuilding Predictive Models in R Using the caret Package
Kuhn, M. (2008) · Journal of Statistical Software · doi:10.18637/jss.v028.i05 · Cited by 8,863 · cited 2×
“Alt AA hydrophobic−side−chain:aromatic (86)”
Method
Research works printed but not linked: 3
- 53. Karczewski, K.J., Francioli, L.C., Tiao, G., Cummings, B.B., Alföldi, J., Wang, Q., Collins, R.L., Laricchia, K.M., Ganna, A., Birnbaum, D.P., et al. (2019). Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv, 531210.
- 89. Satterstrom, F.K., Kosmicki, J.A., Wang, J., Breen, M.S., De Rubeis, S., An, J.-Y., Peng, M., Collins, R.L., Grove, J., Klei, L., et al. (2018a). Novel genes for autism implicate both excitatory and inhibitory cell lineages in risk. bioRxiv, 484113.
- 90. Satterstrom, F.K., Walters, R.K., Singh, T., Wigdor, E.M., Lescai, F., Demontis, D., Kosmicki, J.A., Grove, J., Stevens, C., Bybjerg-Grauholm, J., et al. (2018b). ASD and ADHD have a similar burden of rare protein-truncating variants. bioRxiv, 277707.
Cited by
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
“374 Being trained on sequence ‐ and structure ‐ based features, the ML model predicted the gain or loss of function effects of likely pathogenic missense variants in ion channels and the results were validated in exome ‐ wide data.”
A cross-disorder dosage sensitivity map of the human genome
Collins, R. L., Glessner, J. T., Porcu, E., Lepamets, M., Brandon, R., Lauricella, C., Han, L., Morley, T., Niestroj, L.-M., Ulirsch, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.036 · Cited by 368
Self-citationMVP predicts the pathogenicity of missense variants by deep learning
Qi, H., Zhang, H., Zhao, Y., Chen, C., Long, J. J., Chung, W. K., Guan, Y., & Shen, Y. (2021) · Nature Communications · doi:10.1038/s41467-020-20847-0 · Cited by 198
The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications
Brunklaus, A., Brünger, T., Feng, T., Fons, C., Lehikoinen, A., Panagiotakaki, E., Vintan, M.-A., Symonds, J., Andrew, J., Arzimanoglou, A., et al. (2022) · Brain · doi:10.1093/brain/awac210 · Cited by 167
“al estimation via the in silico prediction tool funNCion, on the basis of a large dataset of voltage-gated sodium and calcium channel presentations.(36) Given the limited predictive certainty of the funNCion tool, paralogue variants should be weighted higher for the function-”
BackgroundMethodSelf-citationHigh-Throughput Reclassification of SCN5A Variants
Glazer, A. M., Wada, Y., Li, B., Muhammad, A., Kalash, O. R., O’Neill, M. J., Shields, T., Hall, L. D., Short, L. L., Blair, M. A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.05.015 · Cited by 144
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
“Thus, it is difficult to predict functional effect based on phenotype, and functional characterisation of variants or use of in silico tools is required 66 .”
Current practice in diagnostic genetic testing of the epilepsies
Krey, I., Platzer, K., Esterhuizen, A. I., Berkovic, S. F., Helbig, I., Hildebrand, M. S., Lerche, H., Lowenstein, D. H., Møller, R. S., Poduri, A., et al. (2022) · Epileptic Disorders · doi:10.1684/epd.2022.1448 · Cited by 127
Self-citationIqbal, S., Pérez-Palma, E., Jespersen, J. B., May, P., Hoksza, D., Heyne, H. O., Ahmed, S. S., Rifat, Z. T., Rahman, M. S., Lage, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002660117 · Cited by 119
“For example, the “voltage-sensing” helical regions of the ion transporters (e.g., sodium channel family) are predominantly enriched with pathogenic missense variations, causing several forms of neurological channelopathies (34–36).”
Self-citationMendelian inheritance revisited: dominance and recessiveness in medical genetics
Zschocke, J., Byers, P. H., & Wilkie, A. O. M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00574-0 · Cited by 127
Gene variant effects across sodium channelopathies predict function and guide precision therapy
Brunklaus, A., Feng, T., Brünger, T., Perez-Palma, E., Heyne, H., Matthews, E., Semsarian, C., Symonds, J. D., Zuberi, S. M., Lal, D., et al. (2022) · Brain · doi:10.1093/brain/awac006 · Cited by 114
“38 recently developed an in-silico prediction tool (‘ funNCion ’; http://funNCion.broadinstitute.org) to estimate the functional consequences of voltage-gated sodium and calcium channels.”
Self-citationPredicting functional effect of missense variants using graph attention neural networks
Zhang, H., Xu, M. S., Fan, X., Chung, W. K., & Shen, Y. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00561-w · Cited by 98
McInnes, G., Sharo, A. G., Koleske, M. L., Brown, J. E. H., Norstad, M., Adhikari, A. N., Wang, S., Brenner, S. E., Halpern, J., Koenig, B. A., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.003 · Cited by 86
Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade
Obergrussberger, A., Friis, S., Brüggemann, A., & Fertig, N. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1791079 · Cited by 75
Lischka, A., Laššuthová, P., Çakar, A., Record, C. J., Lent, J. V., Baets, J., Dohrn, M. F., Senderek, J., Lampert, A., Bennett, D., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00365-7 · Cited by 66
Clinical and genetic characterization of CACNA1A ‐related disease
Lipman, A. R., Fan, X., Shen, Y., & Chung, W. K. (2022) · Clinical Genetics · doi:10.1111/cge.14180 · Cited by 62
Computational analysis of 10,860 phenotypic annotations in individuals with SCN2A-related disorders
Crawford, K., Xian, J., Helbig, K. L., Galer, P. D., Parthasarathy, S., Lewis‐Smith, D., Kaufman, M. C., Fitch, E., Ganesan, S., O’Brien, M., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01120-1 · Cited by 63
Sevim Bayrak, C., Stein, D., Jain, A., Chaudhary, K., Nadkarni, G. N., Van Vleck, T. T., Puel, A., Boisson-Dupuis, S., Okada, S., Stenson, P. D., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.10.007 · Cited by 53
Stein, D., Kars, M. E., Wu, Y., Bayrak, Ç. S., Stenson, P. D., Cooper, D. N., Schlessinger, A., & Itan, Y. (2023) · Genome Medicine · doi:10.1186/s13073-023-01261-9 · Cited by 53
Successful treatment of adult Dravet syndrome patients with cenobamate
Makridis, K. L., Friedo, A., Kellinghaus, C., Losch, F., Schmitz, B., Boßelmann, C. M., & Kaindl, A. M. (2022) · Epilepsia · doi:10.1111/epi.17427 · Cited by 54
The suitability of high throughput automated patch clamp for physiological applications
Obergrussberger, A., Rinke‐Weiß, I., Goetze, T. A., Rapedius, M., Brinkwirth, N., Becker, N., Rotordam, M. G., Hutchison, L., Madau, P., Pau, D., et al. (2021) · The Journal of Physiology · doi:10.1113/jp282107 · Cited by 43
“1 (Calhoun et al. 2017; Kang et al. 2019), hERG (Kozek et al. 2020; Ng et al. 2020), SCN5A (Glazer et al. 2020), Piezo1 (Rotordam et al. 2019) and NaV and CaV channels (Heyne et al. 2020).”
BackgroundInfluentialFunctional correlates of clinical phenotype and severity in recurrent SCN2A variants
Berecki, G., Howell, K. B., Heighway, J., Olivier, N. B., Rodda, J., Overmars, I., Vlaskamp, D. R. M., Ware, T. L., Ardern‐Holmes, S. L., Lesca, G., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03454-1 · Cited by 43
Analysing an allelic series of rare missense variants of CACNA1I in a Swedish schizophrenia cohort
Báez-Nieto, D., Allen, A. S., Akers-Campbell, S., Yang, L., Budnik, N., Pupo, A., Shin, Y.-C., Genovese, G., Liao, M., Pérez‐Palma, E., et al. (2021) · Brain · doi:10.1093/brain/awab443 · Cited by 38
Self-citationZhou, Y., & Lauschke, V. M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2289 · Cited by 39
“31 As discussed above, training and development of these meth-ods rely primarily on the assessment of evolutionary conservation and, accordingly, deleteriousness of a given variant, which most commonly coincides with reduced gene activity.”
BackgroundData-driven historical characterization of epilepsy-associated genes
Macnee, M., Pérez‐Palma, E., López-Rivera, J. A., Ivaniuk, A., May, P., Møller, R. S., & Lal, D. (2022) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2022.12.005 · Cited by 46
Self-citationHack, J., Horning, K. J., Short, D. M. J., Schreiber, J. M., Watkins, J. C., & Hammer, M. F. (2023) · Neurology Genetics · doi:10.1212/nxg.0000000000200060 · Cited by 41
Ng, A. C., Chahine, M., Scantlebury, M. H., & Appendino, J. P. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12352-x · Cited by 37
“In silico tools have been helpful in classifying variants as potentially pathogenic, but these tools remain imperfect [106].”
Bucher, M., Niebling, S., Han, Y., Molodenskiy, D., Hassani Nia, F., Kreienkamp, H.-J., Svergun, D., Kim, E., Kostyukova, A. S., Kreutz, M. R., et al. (2021) · eLife · doi:10.7554/elife.66165 · Cited by 33
Predicting functional effects of ion channel variants using new phenotypic machine learning methods
Boßelmann, C. M., Hedrich, U. B. S., Lerche, H., & Pfeifer, N. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010959 · Cited by 34
“Previously, Heyne et al. demonstrated the use of a machine learning method, gradient boosting, to predict the overall functional effect of missense variants in voltage-gated sodium or calcium channels [27].”
InfluentialSelf-citationSonnek, B., Döring, J. H., Mütze, U., Schubert‐Bast, S., Bast, T., Balke, D., Reuner, G., Schuler, E., Klabunde-Cherwon, A., Hoffmann, G. F., et al. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.10.010 · Cited by 33
Self-citationCenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
Gjerulfsen, C. E., Oudin, M. J., Furia, F., Gverdtsiteli, S., Landmark, C. J., Trivisano, M., Balestrini, S., Guerrini, R., Aledo‐Serrano, Á., Morcos, R., et al. (2025) · Epilepsia · doi:10.1111/epi.18257 · Cited by 31
Self-citationConserved patterns across ion channels correlate with variant pathogenicity and clinical phenotypes
Brünger, T., Pérez‐Palma, E., Montanucci, L., Nothnagel, M., Møller, R. S., Schorge, S., Zuberi, S. M., Symonds, J. D., Lemke, J. R., Brunklaus, A., et al. (2022) · Brain · doi:10.1093/brain/awac305 · Cited by 30
“iants in SCN genes are close to the pore axis in the extracellular side of the membrane, which is the region where the selectivity filter is located, whereas GoF variants cluster in the intracellular site of the membrane.(42) Such knowledge of the molecular functional consequences of a variant may inform treatment dec…”
BackgroundSelf-citation(2024) · doi:10.1038/s41592-024-02409-0 · Cited by 29
Self-citationMYT1L: A systematic review of genetic variation encompassing schizophrenia and autism
Mansfield, P., Constantino, J. N., & Baldridge, D. (2020) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32781 · Cited by 27
“Gain of function of SCN2A is associated with early onset epilepsy, while loss of function of SCN2A is associated with autism or later onset epilepsy (Heyne et al., 2019).”
BackgroundInfluentialBoßelmann, C. M., Hedrich, U. B. S., Müller, P., Sonnenberg, L., Parthasarathy, S., Helbig, I., Lerche, H., & Pfeifer, N. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104115 · Cited by 27
“38 In these channel families, de novo variants are enriched at paralog-conserved sites.”
BackgroundSelf-citationSLC6A1 variant pathogenicity, molecular function and phenotype: a genetic and clinical analysis
Stefanski, A., Pérez‐Palma, E., Brünger, T., Montanucci, L., Gati, C., Klöckner, C., Johannesen, K. M., Goodspeed, K., Macnee, M., Deng, A. T., et al. (2023) · Brain · doi:10.1093/brain/awad292 · Cited by 27
Self-citationThemistocleous, A. C., Baskozos, G., Blesneac, I., Comini, M., Mégy, K., Chong, S., Deevi, S. V. V., Ginsberg, L., Gosal, D. Y., Hadden, R. D. M., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad037 · Cited by 25
Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine
Maksemous, N., Blayney, C. D., Sutherland, H. G. E., Smith, R. A., Lea, R. A., Tran, K. N., Ibrahim, O., McArthur, J. R., Haupt, L. M., Cader, M. Z., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.892820 · Cited by 23
Gorman, K. M., Peters, C. H., Lynch, B., Jones, L., Bassett, D. S., King, M. D., Ruben, P. C., & Rosch, R. E. (2021) · Brain Communications · doi:10.1093/braincomms/fcab235 · Cited by 22
“1 channel can help to accurately predict clinical phenotypes, including response to medications and seizure burden.(24) Here, we report clinical features, in vitro channel biophysical measurements, and in silico modelling results for a patient with a novel SCN1A variant and an unusually severe phenotype: DEE with addi…”
BackgroundNg, C., Farr, J., Young, P. E., Windley, M. J., Perry, M., Hill, A. P., & Vandenberg, J. I. (2021) · Biology Methods and Protocols · doi:10.1093/biomethods/bpab003 · Cited by 21
KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine
Müller, P., Takacs, D. S., Hedrich, U. B. S., Coorg, R. K., Masters, L., Glinton, K. E., Dai, H., Cokley, J. A., Riviello, J. J., Lerche, H., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51742 · Cited by 20
“Although paralogue evidence is not well established in clinical genetics laboratory classification protocols, informatics techniques to exploit channel paralogue datasets are being developed.(14,15) Training of such programs can be helped as more empirical studies of variant pairs, as provided here, become available.”
BackgroundSelf-citationKan, A. S. H., Kusay, A. S., Mohammadi, N. A., Lin, S. X. N., Liao, V. W. Y., Lesca, G., Souci, S., Milh, M., Christophersen, P., Chebib, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413011121 · Cited by 20
“This approach has successfully been used to predict functional changes at sodium and calcium channels ( 21 , 22 ).”
Self-citationMalik, M. A., Faraone, S. V., Michoel, T., & Haavik, J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108530 · Cited by 19
Delineation of functionally essential protein regions for 242 neurodevelopmental genes
Iqbal, S., Brünger, T., Pérez‐Palma, E., Macnee, M., Brunklaus, A., Daly, M. J., Campbell, A. J., Hoksza, D., May, P., & Lal, D. (2022) · Brain · doi:10.1093/brain/awac381 · Cited by 18
“Neurodevelopmental disorders (NDDs) are a group of congenital or early-onset conditions that affect about 2–5% of children worldwide.1,2 NDDs are characterized by neurocognitive deficits with symptoms ranging from mild impairments, allowing those affected to live reasonably everyday lives, to severe disorders that req…”
BackgroundInfluentialSelf-citationPrioritizing de novo potential non-canonical splicing variants in neurodevelopmental disorders
Li, K., Xiao, J., Ling, Z., Luo, T., Xiong, J., Chen, Q., Dong, L., Wang, Y., Wang, X., Jiang, Z., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104928 · Cited by 18
O’Neill, M. J., Sala, L., Denjoy, I., Wada, Y., Kozek, K. A., Crotti, L., Dagradi, F., Kotta, M., Spazzolini, C., Leenhardt, A., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.12.002 · Cited by 19
SCN8A Encephalopathy: Case Report and Literature Review
Fan, H., Lee, H.-F., & Chi, C. (2021) · Neurology International · doi:10.3390/neurolint13020014 · Cited by 16
“Recently, a new technique using a machine learning statistical model was developed to predict LOF or GOF pathogenic variants’ effects, thus providing valuable information regarding the clinical genetics and functional variants of genes of channels to patients, families, and clinicians [53].”
MethodZhong, G., Zhao, Y., Zhuang, D., Chung, W. K., & Shen, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-62318-4 · Cited by 15
“GoF variants encompass alteraQons that perturb the protein from its normal funcQons via increased or novel acQviQes 36; 37 .”
InfluentialBerghold, V. M., Koko, M., Berutti, R., & Plecko, B. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.944784 · Cited by 14
“Paralog-based in silico predictions suggested a LOF effect with high probability (12).”
BackgroundLigand distances as key predictors of pathogenicity and function in NMDA receptors
Montanucci, L., Brünger, T., Bhattarai, N., Boßelmann, C. M., Kim, S., Allen, J. P., Zhang, J., Klöckner, C., Krey, I., Fariselli, P., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae156 · Cited by 17
“On the other hand, protein-specific pathogenicity predictors that can incorporate knowledge on protein-specific structure and function, have been shown to enhance the accuracy of pathogenicity prediction [49, 50, 87, 88] (p1).”
Self-citationRogers, M., Obergrussberger, A., Kondratskyi, A., & Fertig, N. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2329104 · Cited by 13
André, T., van Berkel, A. A., Singh, G., Abualrous, E. T., Diwan, G. D., Schmenger, T., Braun, L., Malsam, J., Toonen, R. F. G., Freund, C., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.03.007 · Cited by 13
“More recent predictors have focused on individual genes or families with a similar improved performance [e.g., FunNCion (35)].”
BackgroundWong, M. M. K., Kampen, R. A., Braden, R. O., Alagöz, G., Hildebrand, M. S., Dingemans, A. J. M., Corbally, J., den Hoed, J., Mendoza, E., Claassen, W. J. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64074-x · Cited by 12
Zhang, Y., Moran, S. P., Allen, A. S., Báez-Nieto, D., Xu, Q., Wang, L. A., Martenis, W. E., Sacher, J. R., Gale, J. P., Weïwer, M., et al. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00233 · Cited by 11
Self-citationWiel, L., Hampstead, J. E., Venselaar, H., Vissers, L. E. L. M., Brunner, H. G., Pfundt, R., Vriend, G., Veltman, J. A., & Gilissen, C. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.12.001 · Cited by 11
Zhao, S. R., Mondéjar‐Parreño, G., Li, D., Shen, M., & Wu, J. C. (2022) · Journal of Visualized Experiments · doi:10.3791/64265 · Cited by 12
Genetics of congenital arrhythmia syndromes: the challenge of variant interpretation
Glazer, A. M. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.102004 · Cited by 11
Cann, K. L., Meents, J., Eswaran, V. S. B., Dohrn, M. F., Bott, R., Maier, A., Bialer, M. G., Hautvast, P. A. I., Erickson, A., Rolke, R., et al. (2021) · Channels · doi:10.1080/19336950.2020.1870087 · Cited by 10
“9 genes not responsible for any pain phenotype, and machine learningbased statistical models point out the difficulty to confirm pathogenicity of channel variants [51].”
BackgroundGhosh, A., Choudhary, G. P., & Medhi, B. (2024) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_81_24 · Cited by 12
“[16,17] The application of AI in toxicity prediction aligns with advancements in data availability and algorithm capabilities.”
Ahangar, A. A., Elhanafy, E., Blanton, H., & Li, J. (2024) · iScience · doi:10.1016/j.isci.2024.110678 · Cited by 11
“7 The GoF and LoF classifications in Na v channels have frequently been employed to categorize disease-associated mutations for interpreting genotype-phenotype relationships, 7,15 predicting the functional impact of novel variants, 17,18 and guiding precision therapy 19,20 for sodium channelopathies.”
Quinn, S., Zhang, N., Fenton, T. A., Brusel, M., Muruganandam, P., Peleg, Y., Giladi, M., Haitin, Y., Lerche, H., Bassan, H., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167127 · Cited by 10
Self-citationNatural history of non-polyglutamine CACNA1A disease in Austria
Indelicato, E., Nachbauer, W., Amprosi, M., Maier, S. C., Unterberger, I., Delazer, M., Kaltseis, K., Kiechl, S. J., Broessner, G., Baumann, M., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12602-y · Cited by 9
“We re-assessed population frequencies based on the latest release of gnomAD (version 4.1) and used a machine learning based method (https:// funnc. shiny apps. io/ shiny appweb/) for computational prediction of variant effect [17].”
MethodInfluentialFurther delineation of phenotypic spectrum of SCN2A ‐related disorder
Richardson, R., Baralle, D., Bennett, C., Briggs, T. A., Bijlsma, E. K., Clayton‐Smith, J., Constantinou, P., Foulds, N. C., Jarvis, J., Jewell, R., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62595 · Cited by 9
“Spasticity and other movement disorders, such as dystonia, chorea, stereotypies, opisthotonus, and oculogyric crises have also been noted in SCN2A disorders (Howell et al., 2015; Takezawa et al., 2018), and these were also observed in this cohort (6/22 patients).”
BackgroundMelgari, D., Calamaio, S., Frosio, A., Prevostini, R., Anastasia, L., Pappone, C., & Rivolta, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076687 · Cited by 11
Fang, Z., Xie, L., Li, X., Gui, J., Yang, X., Han, Z., Luo, H., Huang, D., Chen, H., Li, C., et al. (2022) · Seizure · doi:10.1016/j.seizure.2022.07.018 · Cited by 10
Conserved missense variant pathogenicity and correlated phenotypes across paralogous genes
Brünger, T., Ivaniuk, A., Pérez‐Palma, E., Montanucci, L., Cohen, S. R., Smith, L. A., Parthasarathy, S., Helbig, I., Nothnagel, M., May, P., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03663-x · Cited by 8
“Given that structure determines function, the molecular consequences of variants often relate to their specific position within the protein structure [27].”
Self-citationTchaicha, S., Auvin, S., Beniczky, S., Brunklaus, A., Lagae, L., Perucca, E., Surges, R., Adler, S., Helmstaedter, C., Jansen, F. E., et al. (2026) · Epilepsia Open · doi:10.1002/epi4.70210 · Cited by 8
“164 More recently, Alphafold has been used to create 3D visualizations of the protein structure of hundreds of genes associated with neurodevelopmental diseases including epilepsy.”
Self-citationKürekçi, F., Kılıç, M. A., Akbaş, S., Avci, R., Oney, C., Aslanger, A. D., Genç, H. M., Aydınli, N., & Yıldız, E. P. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109930 · Cited by 8
Prophecy or empiricism? Clinical value of predicting versus determining genetic variant functions
Brunklaus, A., George, A. L., Lal, D., Heinzen, E. L., & Goldman, A. M. (2023) · Epilepsia · doi:10.1111/epi.17743 · Cited by 8
“6 Furthermore, essential protein regions are conserved among paralog gene-family members, and identification of pathogenic variant enriched regions across voltage-gated sodium channels is a useful indicator of variant similarity and can empower variant interpretation.”
BackgroundSelf-citationHack, J., Watkins, J. C., & Hammer, M. F. (2024) · Biology Open · doi:10.1242/bio.060286 · Cited by 8
“Alternative methods exist for classifying variants as GOF or LOF (Bosselmann et al., 2023; Brunklaus et al., 2022; Heyne et al., 2020).”
MethodXenakis, M. N., Kapetis, D., Yang, Y., Heijman, J., Waxman, S. G., Lauria, G., Faber, C. G., Smeets, H. J. M., Lindsey, P. J., & Westra, R. L. (2021) · Journal of Biological Physics · doi:10.1007/s10867-021-09565-w · Cited by 9
Genotype‐function‐phenotype correlations for SCN1A variants identified by clinical genetic testing
Knox, A. T., Thompson, C. H., Scott, D., Abramova, T. V., Stieve, B. J., Freeman, A., & George, A. L. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52297 · Cited by 9
“In contrast to other in silico prediction models that use genetic and clinical data 32,33 or phenotype, 19 our study uses in silico biophysical neuron modeling to predict how channel dysfunction affect neuron firing.”
Vivekanandam, V., Ellmers, R., Jayaseelan, D. L., Houlden, H., Männikkö, R., & Hanna, M. G. (2022) · Brain · doi:10.1093/brain/awac431 · Cited by 9
Evaluation of burden of SCN1A pathogenicity in North Indian children with Dravet syndrome
Negi, S., Bhatia, P., Kaur, A., Das, J., Bhatia, T., Aggarwal, R., Sankhyan, N., Singhi, P., & Sahu, J. K. (2024) · Seizure · doi:10.1016/j.seizure.2024.09.004 · Cited by 7
GoFCards: an integrated database and analytic platform for gain of function variants in humans
Zhao, W., Tao, Y., Xiong, J., Liu, L., Wang, Z., Shao, C., Shang, L., Hu, Y., Xu, Y., Su, Y., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1079 · Cited by 7
Kurganov, E., Cui, L., Budnik, N., Chen, S., Olivares, E., Báez-Nieto, D., Asan, A. S., Lusk, L. G., Smith, L. A., Jo, S., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr0024 · Cited by 6
Self-citationKrishna, S., Fasaludeen, A., Jose, M., Banerjee, M., Sundaram, S., Radhakrishnan, A., & Menon, R. N. (2024) · Seizure · doi:10.1016/j.seizure.2024.01.004 · Cited by 6
McTague, A., Scheffer, I. E., Kullmann, D. M., & Sisodiya, S. M. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90820-7.00016-1 · Cited by 8
Hydropathicity-based prediction of pain-causing NaV1.7 variants
Xenakis, M. N., Kapetis, D., Yang, Y., Gerrits, M. M., Heijman, J., Waxman, S. G., Lauria, G., Faber, C. G., Westra, R. L., Lindsey, P. J., et al. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04119-2 · Cited by 6
MLe-KCNQ2: An Artificial Intelligence Model for the Prognosis of Missense KCNQ2 Gene Variants
Sáez-Matía, A., Ibarluzea, M. G., M‐Alicante, S., Muguruza‐Montero, A., Núñez, E., Ramis, R., Ballesteros, Ó. R., Lasa-Goicuria, D., Fons, C., Gallego, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052910 · Cited by 5
Li, B., Jin, B., Capra, J. A., & Bush, W. S. (2022) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-122220-112147 · Cited by 5
Okubo, Y., Shibuya, M., Nakamura, H., Kawashima, A., Kodama, K., Endo, W., Inui, T., Togashi, N., Aihara, Y., Shirota, M., et al. (2023) · Brain and Development · doi:10.1016/j.braindev.2023.06.009 · Cited by 6
Pathogenicity of de novo CACNA1D Ca2+ channel variants predicted from sequence co-variation
Tang, X., Ortner, N. J., Nikonishyna, Y. V., Fernández‐Quintero, M. L., Kokot, J., Striessnig, J., & Liedl, K. R. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01594-y · Cited by 5
“However, when training pathogenicity models with all types of features included, sequence conservation remains the most dominant one [21, 22].”
BackgroundGenetic Landscape of SCN1A Variants in a Turkish Cohort with GEFS+ Spectrum and Dravet Syndrome
Türkyılmaz, A., Tekin, E., Yaralı, O., & Çebi, A. H. (2022) · Molecular Syndromology · doi:10.1159/000521330 · Cited by 6
“These web based tools can help researchers and clinicians to interpret their variants [Heyne et al., 2020].”
BackgroundHu, Y., Dong, D., Zhao, J., Hu, K., Kong, L., Hu, Y.-X., Li, X., Li, S.-Y., Nian, Y., & Xu, G. (2025) · Organic Chemistry Frontiers · doi:10.1039/d4qo02233e · Cited by 4
Artificial intelligence for Brugada syndrome diagnosis and gene variants interpretation
Sahebnasagh, M., & Farjoo, M. H. (2025) · American Journal of Cardiovascular Disease · doi:10.62347/yqhq1079 · Cited by 4
Pathogenic in-Frame Variants in SCN8A: Expanding the Genetic Landscape of SCN8A-Associated Disease
Wong, J. C., Butler, K. M., Shapiro, L. E., Thelin, J. T., Mattison, K. A., Garber, K. B., Goldenberg, P. C., Kubendran, S., Schaefer, G. B., & Escayg, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.748415 · Cited by 4
VariBench, new variation benchmark categories and data sets
Shirvanizadeh, N., & Vihinen, M. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1248732 · Cited by 4
Johannesen, K. M., Gardella, E., Ahring, P. K., & Møller, R. S. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104577 · Cited by 4
Self-citationZhang, Y., Grimwood, A. L., Hancox, J. C., Harmer, S. C., & Dempsey, C. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1010119 · Cited by 5
“, (Heyne et al., 2020; Zhang et al., 2020; Phul et al., 2022)] may improve variant phenotype predictability, although experimental phenotyping is still required to improve confidence for clinical decision making.”
BackgroundFasaludeen, A., McTague, A., Jose, M., Banerjee, M., Sundaram, S., Madhusoodanan, U. K., Radhakrishnan, A., & Menon, R. N. (2024) · Epilepsy Research · doi:10.1016/j.eplepsyres.2024.107341 · Cited by 4
Syu, Y.-M., Lee, I., Lu, J., Hung, P., Hong, S., Yang, M., & Liang, J. (2024) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2024.03.013 · Cited by 4
Advancing Ion Channel Research with Automated Patch Clamp (APC) Electrophysiology Platforms
Bell, D. C., & Dallas, M. L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-4254-8_2 · Cited by 6
Artificial Intelligence and Machine Learning in Electrophysiology—a Short Review
Khan, S., Lim, C., Chaudhry, H. A., Assaf, A. Y. M., Donnellan, E. P., Marrouche, N. F., & Kreidieh, O. (2023) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-023-01004-4 · Cited by 4
Venkatesan, S., Nazarkina, D., Sullivan, M. T., Tan, Y., Qu, S., Ramsey, A. J., & Lambe, E. K. (2025) · iScience · doi:10.1016/j.isci.2025.114301 · Cited by 5
“61,62 While receptor-level impact is a first step to predict variant pathogenicity, functional context is essential to determine overall phenotype and predict treatments.”
Rosch, R. E., & Goldberg, E. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89932-1.00015-9 · Cited by 4
Decoding Artificial Intelligence in Neuroscience: Applications Beyond Diagnosis
Salave, S., Rana, D., Benival, D. M., & Jain, A. (2023) · Current Indian Science · doi:10.2174/2210299x01666230223104508 · Cited by 4
Advances in genotype-phenotype associations for CACNA1A-related epilepsies
Brunklaus, A. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.07.001 · Cited by 3
Self-citationLi, N., Zhang, X., Mazaika, E., Theotokis, P. I., Jang, M., Ahmad, M., Powell, G., Heyne, H., Lal, D., Barton, P. J. R., et al. (2023) · Research Square · doi:10.1101/2023.08.07.552236 · Cited by 4
Self-citationTöfflinger, E. V., Makridis, K. L., Heim, M. ‐., Owald, D., & Kaindl, A. M. (2025) · Epilepsia Open · doi:10.1002/epi4.70101 · Cited by 2
Boßelmann, C. M., Wagner, M., Borggräfe, I., Brandt, C., Didt, S., Fazeli, W., Grimmer, A., Kegele, J., Klein, K. M., Kluger, G. J., et al. (2026) · Clinical Epileptology · doi:10.1007/s10309-026-00832-1 · Cited by 2
Self-citation
Metadata
- Authors
- Heyne, H. O., Baez-Nieto, D., Iqbal, S., Palmer, D. S., Brunklaus, A., May, P., Collaborative, E., Johannesen, K. M., Lauxmann, S., Lemke, J. R., Møller, R. S., Pérez-Palma, E., Scholl, U. I., Syrbe, S., Lerche, H., Lal, D., Campbell, A. J., Wang, H.-R., Pan, J., & Daly, M. J.
- Affiliations
- Broad Institute (US)
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Royal Hospital for Children (GB)
- University of Luxembourg (LU)
- University of Southern Denmark (DK)
- University Hospital Leipzig (DE)
- Cleveland Clinic (US)
- Cologne Center for Genomics (CCG), University of Cologne, 50923, Germany.
- University Hospital Heidelberg (DE)
- Corresponding author
- Heyne, Henrike O.
- Iqbal, Sumaiya
- Palmer, Duncan S.
- Daly, Mark J.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2020-08-12
- Volume
- 12
- Issue
- 556
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3048479836
- Cited by
- 140
- References
- 135
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 25 · 2023: 18 · 2022: 30 · 2021: 20 · 2020: 7
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- Funders
- National Institute of Mental Health (5U01MH094432-02, R01 MH115045-01)
- National Human Genome Research Institute (HG008895)
- National Institute of Neurological Disorders and Stroke (U54 NS108874, R21 NS108874)
- Simons Foundation (SFARI 311789)
- Deutsche Forschungsgemeinschaft (LE1030/15-1, LE1030/16-1, Research Unit FOR-2715, HE7987/1-1, HE7987/1-2)
- Bundesministerium für Bildung und Forschung (Treat-ION)
- Horizon 2020 (JPND-Courage-PD)
- Stanley Foundation
- Stiftung Charite
- Dietmar Hopp Stiftung (23011236)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- missense mutations, voltage-gated sodium channels, voltage-gated calcium channels, ion channel disorders, loss of function, gain-of-function, functional prediction, machine learning, human genetic variants
- MeSH terms
- Pharmaceutical Preparations, Phenotype, Sodium, Calcium Channels, Mutation, Missense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.